FAC Explorer

Audit 395451

FY End
2025-06-30
Total Expended
$5.79M
Findings
2
Programs
4
Organization: Clinica Msr. Oscar A. Romero (CA)
Year: 2025 Accepted: 2026-03-27
Auditor: CLIFTONLARSONALLEN LLP

Organization Exclusion Status:

Findings

ID Ref Severity Repeat Requirement
1191584 2025-001 Material Weakness Yes N
1191585 2025-002 Material Weakness Yes I

Programs

ALN Program Spent Major Findings
93.493 CONGRESSIONAL DIRECTIVES $854,094 Yes 1
93.527 GRANTS FOR NEW AND EXPANDED SERVICES UNDER THE HEALTH CENTER PROGRAM $500,476 Yes 0
93.224 HEALTH CENTER PROGRAM (COMMUNITY HEALTH CENTERS, MIGRANT HEALTH CENTERS, HEALTH CARE FOR THE HOMELESS, AND PUBLIC HOUSING PRIMARY CARE) $370,297 Yes 0
93.526 GRANTS FOR CAPITAL DEVELOPMENT IN HEALTH CENTERS $321,149 Yes 0

Contacts

Name Title Type
GJYNK93MJKC5 Marcelo Villagomez Auditee
2135012738 Christine M Abell Auditor
No contacts on file

Notes to SEFA

The accompanying schedule of expenditures of federal awards (the Schedule), includes the federal award activity of Clinica Msr. Oscar A. Romero under programs of the federal government for the year ended June 30, 2025. The information in the Schedule is presented in accordance with the requirements of 2 CFR Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of Clinica Msr. Oscar A. Romero, it is not intended to and does not present the financial position, changes in net assets, or cash flows of Clinica Msr. Oscar A. Romero.
Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement.
Clinica Msr. Oscar A Romero has elected not to use the 10% de minimis indirect cost rate as allowed under the Uniform Guidance.

Finding Details

Finding 2025-001
During our compliance testing of sliding fee discounts, we identified one instance in which Clinica did not apply its sliding fee discount policy in accordance with established internal requirements. Specifically, a sliding fee discount was granted to a patient after the patient had been determined to be non‑compliant per Clinica’s income verification procedures and therefore ineligible for the discount.
Finding 2025-002
During our compliance testing of suspension and debarment verification, Clinica did not verify that the vendor utilized for construction was not suspended, debarred, or otherwise excluded from participating in a covered transaction prior to engaging with the vendor.